Comparison of D-dimer Levels Based on COVID-19 Severity Degree in Third-trimester Pregnant Women at dr. Doris Sylvanus Hospital
Keywords:
Pregnant women, D-dimer levels, COVID-19Abstract
Pregnant women are vulnerable to COVID-19 due to the physiological adaptive changes and immunosuppressive state during pregnancy. Various studies on COVID-19 patients have shown the prognostic value of elevated D-dimer. Pregnant women with COVID-19 experience hypercoagulability and hyperfibrinolysis, as indicated by the increased D-dimer levels that exceed normal limits during pregnancy. This study aims to determine the comparison of D-dimer levels based on the COVID-19 severity degree in third-trimester pregnant women at dr. Doris Sylvanus Hospital Palangka Raya. This research is an analytical observational study with a cross-sectional design. It used the medical record data of third-trimester pregnant women confirmed positive for COVID-19 who underwent D-dimer examination at dr. Doris Sylvanus Hospital, Palangka Raya, during November 2020–October 2021, and limited to be generalized to places that has similarity with this hospital. Descriptive analysis in this study used the Kruskal Wallis test and Mann Whitney test. There is a significant difference in D-dimer levels based on the severity of COVID-19 with mild and moderate severity as indicated by the p=0.000 value. In mild and severe severity, the value of p=0.001 means that there is a significant difference, whereas in moderate and severe severity showed a value of p=0.101 which means there was no significant difference. Mild severity has median 1.21, Moderate 2.71 and Severe 4.20. D-dimer and SpO2 data showed non-normally distributed data. It is an important topic to be studied because D-dimer levels can be the parameter for patients with COVID-19 severity status.
References
Aulia Ramadhan MA, Sawitri E, Wahyunie S. Association of Neutrophil-Lymphocyte Ratio (NLR) and D-Dimer Levels with COVID-19 Mortality. J Kesehat Pasak Bumi Kalimantan [Internet]. 2022;5(2):167–73. Available from: https://e-journals.unmul.ac.id/index.php/JKPBK
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Napoli R Di. Features, Evaluation, and Treatment of Coronavirus (COVID-19) [Internet]. National Library of Medicine. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - J Am Med Assoc. 2020;324(8):782–93.
Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia 2021. Kementerian Kesehatan Republik Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia; 2022. 1–285 p.
Wang Z, Wang Z, Xiong G. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China. Int J Gynecol Obstet. 2020;150(3):312–7.
Fauzan F, Sriyanti R, Djanas D, Nindrea RD. Analisis Ketahanan Hidup Ibu Hamil dengan COVID 19 Berdasarkan Kadar D-Dimer Terhadap Luaran di RSUP DR. M. Djamil, Padang. Syntax Lit J Ilm Indones. 2022;7(6):8734–42.
Prawirohardjo S. Ilmu Kebidanan. Keempat. Saifuddin AB, Rachimhadhi T, Wiknjosastro GH, editors. Jakarta: PT. Bina Pustaka Sarwono Prawirohardjo; 2008. 1–765 p.
Bagian Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjajaran Bandung. Obstetri Fisiologi. Bandung: Eleman; 1983. 1–338 p.
Rustam M. Sinopsis Obstetri. Second. Lutan D, editor. Jakarta: Penerbit Buku Kedokteran EGC; 1998. 1–453 p.
Sunardi Asih NW. Hubungan NLR, Kadar CRP dan D-dimer Terhadap Derajat Keparahan Penyakit Pasien COVID-19 di RSUD Wangaya Denpasar. J Med Udayana [Internet]. 2022;11(12):14–21. Available from: http://ojs.unud.ac.id/index.php/eum
Amelia R, Nur Anissa DF, Luhulima D. Perbedaan Peningkatan Kadar D-dimer pada Dewasa dan Lansia yang Terkonfirmasi COVID-19 di RS Swasta Bintaro. J Res Educ Chem. 2022;4(1):1.
Putri Pradnyasari SAN, Hidayat M, Fathana PB. Hubungan Kadar D-dimer dan C-Reactive Protein terhadap Berat Gejala pada Pasien COVID-19. J Kedokt Unram. 2022;11(4):1192–7.
Darmawan NWAN, Bayuningrat IGNM, Witari NPD. Hubungan antara Usia, Usia Kehamilan, Kadar Leukosit, dan Paritas dengan Tingkat Keparahan Gejala Covid-19 pada Ibu Hamil di Rumah Sakit Umum Daerah Sanjiwani Gianyar pada Tahun 2020-2021. Aesculapius Med J. 2023;3(2):277–83.
Pradnya Angela KA, Duwi Sumohadi IM. Hubungan D-dimer dengan Tingkat Keparahan Infeksi COVID-19. Intisari Sains Medis. 2022;13(2):393–8.
World Health Organization. TRENDS IN MATERNAL MORTALITY: 2000 TO 2017 [Internet]. Vol. WHO/RHR/19. Geneva: World Health Organization; 2019. Available from: https://www.unfpa.org/sites/default/files/pub-pdf/Maternal_mortality_report.pdf
Alifiah N, E. Berhimpon SL, Rambert GI. Description of Leucocyte Differential Count in Pregnant Women with COVID-19. Med Scope J [Internet]. 2022;3(2):151–6. Available from: https://ejournal.unsrat.ac.id/index.php/msj/index
Prawirohardjo S. Ilmu Kebidanan. 4th ed. Jakarta: Bina Pustaka Sarwono Prawirohardjo; 2010.
Manopo FF, E. Berhimpon SL, Wowor MF. Gambaran Hematologi pada Wanita Hamil Trimester 3 yang Terkonfirmasi Positif SARS-CoV-2 di RSUP Prof. Dr. R.D. Kandou Periode Juli-September 2020. e-Biomedik. 2021;9(1):46–51.
Centers of Diseases and Control Prevention. Pregnant and Recently Pregnant People at Increased Risk for Severe Illness from COVID-19 [Internet]. Georgia: Centers for Disease Control and Prevention; 2022. p. 1–4. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html
Li H, Liu S ming, Yu X hua, Tang S lin, Tang C ke. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents [Internet]. 2020;55(5):1–8. Available from: https://www.sciencedirect.com/science/article/pii/S0924857920301011?via%3Dihub
Reiki H, Armanza F, Aditya R, Hendriyono FX, Rahmiati. Perbedaan Kadar D-Dimer pada Ibu Hamil dengan COVID-19 Tanpa dan Disertai Preeklampsia: Penelitian di RSUD Ulin Banjarmasin Periode Maret 2020-Februari 2022. Homeostasis. 2023;6(1):51–8.
Octaviani Katili DN, Husna Ali RN, Puspita N, Paramata A. Kualitas Hidup Wanita dengan Kehamilan Risiko Tinggi pada Masa Pandemi COVID-19. Heal Inf J Penelit [Internet]. 2022;14(2):219–28. Available from: https://myjurnal.poltekkes-kdi.ac.id/index.php/hijp/article/view/676
Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020;144(7):799–805.
Sagita W. Faktor-Faktor yang Berhubungan dengan Pengetahuan Ibu Hamil Tentang COVID-19 di Wilayah Jabodetabek Tahun 2020. J Ilm Kesehat BPI. 2021;5(1):1–5.
Badan Pusat Statistik Kalimantan Tengah. Provinsi Kalimantan Tengah Dalam Angka 2022. 2022;1–863.
Fernandez E. COVID-19 During Pregnancy Associated with Preterm Birth [Internet]. The Lancet Regional Health-Americas. 2021 [cited 2023 Dec 1]. Available from: https://www.ucsf.edu/news/2021/08/421181/covid-19-during-pregnancy-associated-preterm-birth
Gustian H, Budi Pratiwi RA, Riantie R. Comparison of D-Dimer Level on Mild, Moderate and Severe COVID-19 at Immanuel Hospital Bandung City October 1st - December 31st, 2020. Blood [Internet]. 2021;138(November):4268. Available from: https://ashpublications.org/blood/article/138/Supplement 1/4268/481600/Comparison-of-D-Dimer-Level-on-Mild-Moderate-and
Atmaja KS, Wicaksana AAGOS, Putra IWAS, Putra WWS. Hubungan konsentrasi serum C-Reactive Protein dan D-dimer dengan derajat keparahan dan mortalitas pasien COVID-19. Intisari Sains Medis. 2021;12(2):680–5.
Wati L, Nugraheni DM, Ratnaningrum K, Novitasari A. C-Reactive Protein Berkorelasi Terhadap Kadar D-Dimer Pasien COVID-19. Al-Iqra Med J J Berk Ilm Kedokt. 2021;5(1):1–9.
Patil S, Acharya A, Gondhali G, Narwade G. Does Follow-up D-Dimer Level Help in Predicting Oxygenation Status, Ventilatory Support Requirement, Lung Fibrosis, and Thromboembolic Events in Coronavirus Disease 2019 Pneumonia? A Prospective Observational Study in a Tertiary Care Setting in India. Ann Afr Med [Internet]. 2023;22(3):286–92. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445714/
Published
How to Cite
Issue
Section
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
